Abstract
Abstract
Purpose
The perioperative consequences of direct oral anticoagulants (DOACs) in hip fracture patients are not sufficiently investigated. The primary aim of this study was to determine whether DOAC-users have delayed surgery compared to non-users. Secondarily, we studied whether length of hospital stay, mortality, reoperations and bleeding complications were influenced by the use of DOAC.
Methods
The medical records of 314 patients operated for a hip fracture between 2016 and 2017 in a single trauma center were assessed. Patients aged < 60 and patients using other forms of anticoagulation than DOACs were excluded. Patients were followed from admission to 6 months postoperatively. Surgical delay was defined as time from admission to surgery. Secondary outcomes included length of hospital stay, transfusion rates, perioperative bleeding loss, postoperative wound ooze, mortality and risk of reoperation. The use of general versus neuraxial anaesthesia was registered. Continuous outcomes were analysed using Students t test, while categorical outcomes were expressed by Odds ratios.
Results
47 hip fracture patients (15%) were using DOACs. No difference in surgical delay (29 vs 26 h, p = 0.26) or length of hospital stay (6.6 vs 6.1 days, p = 0.34) were found between DOAC-users and non-users. DOAC-users operated with neuraxial anaesthesia had longer surgical delay compared to DOAC-users operated with general anaesthesia (35 h vs 22 h, p < 0.001). Perioperative blood loss, transfusion rate, risk of bleeding complications and mortality were similar between groups.
Conclusion
Hip fracture patients using DOAC did not have increased surgical delay, length of stay or risk of reported bleeding complications than patients without anticoagulation prior to surgery. The increased surgical delay found for DOAC-users operated with neuraxial anaesthesia should be interpreted with caution.
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. No authors listed (2019) Norwegian Institute of Public Health, The prescription registry. Indivual site for retrieving data accessed 05.12.19. https://reseptregisteret.no/Prevalens.aspx
2. de Jong LA, Knoops M, Gout-Zwart JJ, Beinema MJ, Hemels MEW, Postma MJ, Boruwers JRBJ (2018) Trends in direct oral anticoagulant (DOAC) use: health benefits and patient preference. Neth J Med 76(10):426–430
3. Solbakken SM, Meyer HE, Stigum H, Søgaard AJ, Holvik K, Magnus JH, Omsland TK (2017) Excess mortality following hip fracture: impact of self-perceived health, smoking, and body mass index. A NOREPOS study. Osteoporos Int 28(3):881–887
4. Verma A, Ha ACT, Rutka JT, Verma S (2018) what surgeons should know about non-vitamin K oral anticoagulants: a review. JAMA Surg 153(6):577–585
5. Vera-Llonch M, Hagivara M, Oster G (2006) Clinical and economic consequences of bleeding following major orthopedic surgery. Thromb Res 117(5):569–577
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献